NASDAQ:ZBIOProShares UltraPro Short Nasdaq Biotechnology Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ProShares UltraPro Short Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $10.02 0.00 (0.00 %) (As of 05/25/2020 04:00 PM ET) Add Share Today's Range$10.02Now: $10.02▼$10.0250-Day Range$10.02MA: $10.05▼$10.0952-Week Range$8.28Now: $10.02▼$18.64VolumeN/AAverage Volume32,378 shsMarket Capitalization$2.51 millionP/E RatioN/ADividend Yield0.36%BetaN/A ProfileAdvanced ChartDividendInstitutional OwnershipHeadlinesOptions ChainSocial Media Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for ProShares UltraPro Short Nasdaq Biotechnology. Previous Next 2.3 Community Rank Outperform VotesProShares UltraPro Short Nasdaq Biotechnology has received 58 “outperform” votes. (Add your “outperform” vote.)Underperform VotesProShares UltraPro Short Nasdaq Biotechnology has received 68 “underperform” votes. (Add your “underperform” vote.)Community SentimentProShares UltraPro Short Nasdaq Biotechnology has received 53.97% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about ProShares UltraPro Short Nasdaq Biotechnology and other stocks. Vote “Outperform” if you believe ZBIO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ZBIO will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend LeadershipProShares UltraPro Short Nasdaq Biotechnology is a leading dividend payer. It pays a dividend yield of 0.36%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthProShares UltraPro Short Nasdaq Biotechnology does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ProShares UltraPro Short Nasdaq Biotechnology insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.79 out of 5 stars Basic Details Issuer ProShares Fund NameProShares UltraPro Short Nasdaq Biotechnology Tax ClassificationRegulated Investment Company SymbolNASDAQ:ZBIO Inception Date6/22/2015 Fund ManagerMichael Neches, Tarak Dave WebN/A PhoneN/A Fund Focus Asset ClassEquity BenchmarkNASDAQ Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$2.85 million Average Daily Volume$25,501.70 Discount/Premium0.00% ETF Expenses Management Fee0.75% Other Expenses1.02% Total Expenses1.77% Fee Waiver-0.82% Net Expenses0.95%Administrator, Advisor and Custodian AdministratorJ.P. Morgan Investor Services Co. AdvisorProShare Advisors LLC CustodianJPMorgan Chase Bank, N.A. DistributorSEI Investments Distribution Co. Transfer AgentJPMorgan Chase Bank, N.A. Trustee Lead Market MakerVirtu Financial NASDAQ:ZBIO Rates by TradingView Receive ZBIO News and Ratings via Email Sign-up to receive the latest news and ratings for ZBIO and its competitors with MarketBeat's FREE daily newsletter. ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) Frequently Asked Questions How has ProShares UltraPro Short Nasdaq Biotechnology's stock been impacted by COVID-19 (Coronavirus)? ProShares UltraPro Short Nasdaq Biotechnology's stock was trading at $11.68 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ZBIO shares have decreased by 14.2% and is now trading at $10.0204. View which stocks have been most impacted by Coronavirus. How often does ProShares UltraPro Short Nasdaq Biotechnology pay dividends? What is the dividend yield for ProShares UltraPro Short Nasdaq Biotechnology? ProShares UltraPro Short Nasdaq Biotechnology announced a quarterly dividend on Tuesday, December 24th. Shareholders of record on Thursday, December 26th will be paid a dividend of $0.002 per share on Thursday, January 2nd. This represents a $0.01 dividend on an annualized basis and a yield of 0.08%. The ex-dividend date of this dividend is Tuesday, December 24th. View ProShares UltraPro Short Nasdaq Biotechnology's dividend history. Has ProShares UltraPro Short Nasdaq Biotechnology been receiving favorable news coverage? Media coverage about ZBIO stock has trended negative on Tuesday, InfoTrie reports. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. ProShares UltraPro Short Nasdaq Biotechnology earned a coverage optimism score of -2.1 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutProShares UltraPro Short Nasdaq Biotechnology. What other stocks do shareholders of ProShares UltraPro Short Nasdaq Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares UltraPro Short Nasdaq Biotechnology investors own include ProShares UltraPro Short QQQ (SQQQ), ProShares UltraPro QQQ (TQQQ), Immunomedics (IMMU), Direxion Daily S&P Biotech Bear 3x Shares (LABD), Direxion Daily S&P Biotech Bull 3x Shares (LABU), Direxion Daily Semiconductors Bull 3x Shares (SOXL), Direxion Daily Small Cap Bull 3X Shares (TNA), Direxion Daily Small Cap Bear 3X Shares (TZA), Verizon Communications (VZ) and Eaton Vance Tax Managed Buy Write Opport (ETV). What is ProShares UltraPro Short Nasdaq Biotechnology's stock symbol? ProShares UltraPro Short Nasdaq Biotechnology trades on the NASDAQ under the ticker symbol "ZBIO." How do I buy shares of ProShares UltraPro Short Nasdaq Biotechnology? Shares of ZBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is ProShares UltraPro Short Nasdaq Biotechnology's stock price today? One share of ZBIO stock can currently be purchased for approximately $10.02. How big of a company is ProShares UltraPro Short Nasdaq Biotechnology? ProShares UltraPro Short Nasdaq Biotechnology has a market capitalization of $2.51 million. This page was last updated on 5/26/2020 by MarketBeat.com Staff
